Your Health Plan:
Your Health Plan:
Not SelectedRESTASIS (cyclosporine) is a brand-name prescription drug for treatment of Inflammatory abnormality of the eye and Keratoconjunctivitis Sicca. RESTASIS is a calcineurin inhibitor immunosuppressant. It is available in the form of ophthalmic emulsion.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $350-830.
Patient Assistance Prorgams and Coupons are found:
Other alternatives to RESTASIS may include: